Act Methylphenidate ER 36 mg

ACT Methylphenidate ER 36 mg is an extended-release tablet designed for oral use. It contains methylphenidate hydrochloride, a central nervous system stimulant. This medication is commonly used to manage symptoms of ADHD and may help improve focus and concentration.

ACT Methylphenidate ER 36 mg is primarily used to treat attention deficit hyperactivity disorder (ADHD). It works by affecting certain chemicals in the brain that may be unbalanced in people with ADHD. This can help improve focus, reduce impulsivity, and enhance concentration. The extended-release formulation is designed to provide a steady release of the medication over time, which can help maintain its effects throughout the day.

Common effects of ACT Methylphenidate ER 36 mg may include increased alertness, improved focus, and enhanced concentration. Some individuals may experience side effects such as decreased appetite, insomnia, or mild stomach upset. These effects can vary from person to person and may not be experienced by everyone who takes the medication.

ACT Methylphenidate ER 36 mg should be handled with care and stored properly to maintain its effectiveness. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms. Always consult a healthcare provider before starting or stopping any medication.

ACT Methylphenidate ER 36 mg may interact with other medications, including certain antidepressants, blood pressure medications, and other stimulants. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, consuming alcohol while taking this medication may increase the risk of side effects.